美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Zenas BioPharma Inc.

31.91

+0.79002.54%

盤前：32.490.5800+1.82%07:00 EDT

成交量：63.46萬

成交額：2,003.56萬

市值：20.80億

市盈率：-3.53

高：32.00

開：31.00

低：30.66

收：31.12

52周最高：44.60

52周最低：13.50

股本：6,517.67萬

流通股本：4,502.47萬

量比：1.35

換手率：1.41%

股息：- -

股息率：- -

每股收益(TTM):-9.0522

每股收益(LYR):-8.4448

淨資產收益率：-199.04%

總資產收益率：-34.42%

市淨率：8.42

市盈率(LYR):-3.78

資料載入中...

總覽公司新聞資訊公告

Zenas BioPharma提交招股文件：賣股股東擬發售最高700萬股普通股

Zenas Biopharma宣佈Obexelimab三期INDIGO試驗達成主要及所有關鍵次要終點

Zenas BioPharma公布Obexelimab治療IgG4相關疾病關鍵3期INDIGO試驗數據，同步亮相EULAR 2026大會並發表於《新英格蘭醫學雜誌》

Zenas BioPharma宣佈向美國FDA提交Obexelimab治療IgG4-RD的生物製品許可申請

異動解讀 | 澤納斯生物製藥盤前大漲6.45%，因將公布關鍵藥物3期試驗結果

澤納斯生物製藥宣佈將在2026年歐洲抗風濕病聯盟大會上公布奧貝昔利單抗治療IgG4相關疾病的3期INDIGO註冊試驗結果

Zenas Biopharma宣佈其潛在同類最佳口服IL-17Aa/Af抑制劑ZB021完成首例受試者給藥

BUZZ--美國股票走勢-Entergy 公司、IDEX 公司、廣達服務公司

BUZZ--美國股票走勢-Entergy 公司、IDEX 公司、廣達服務公司

Zenas BioPharma完成3億美元融資：發行可轉債與普通股，加速自免藥物開發

BUZZ-Zenas 生物製藥公司因發行可轉換債券和股票而下跌

Zenas BioPharma Inc. 融資收益將用於支持Obexelimab美國上市、管線推進及一般企業用途

Zenas BioPharma宣佈擬同步公開發行2032年到期可轉換優先票據及普通股

Zenas BioPharma 公布2025年第四季度及全年財務業績並更新公司進展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/ZBIO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ZBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","market":"US","secType":"STK","nameCN":"Zenas BioPharma Inc.","latestPrice":31.91,"timestamp":1789416000000,"preClose":31.12,"halted":0,"volume":634641,"hourTrading":{"tag":"盘前","latestPrice":32.49,"preClose":31.91,"latestTime":"07:00 EDT","volume":3,"amount":96.122406,"timestamp":1789470007157,"change":0.58,"changeRate":0.018176,"amplitude":0.021116},"delay":0,"changeRate":0.025385604113110513,"floatShares":45024692,"shares":65176700,"eps":-9.052203,"marketStatus":"盤前交易","change":0.79,"latestTime":"09-15 08:35:47 EDT","open":31,"high":32,"low":30.66,"amount":20035617.639282,"amplitude":0.043059,"askPrice":32.67,"askSize":1,"bidPrice":27.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-9.052203,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":31.91,"sharesOutstanding":249967,"nav":10.0592,"aum":2514468.0464,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":32.49,"preClose":31.91,"latestTime":"07:00 EDT","volume":3,"amount":96.122406,"timestamp":1789470007157,"change":0.58,"changeRate":0.018176,"amplitude":0.021116},"postHourTrading":{"tag":"盘后","latestPrice":32.5602,"preClose":31.91,"latestTime":"19:30 EDT","volume":22992,"amount":737232.9155,"timestamp":1789428601285,"change":0.6502,"changeRate":0.020376,"amplitude":0.034159},"volumeRatio":1.3515008227436547,"impliedVol":0.7414,"impliedVolPercentile":0.28},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","floatShares":45024692,"roa":"-34.42%","roe":"-199.04%","lyrEps":-8.444814,"volumeRatio":1.3515008227436547,"shares":65176700,"dividePrice":0,"high":32,"amplitude":0.043059,"preClose":31.12,"low":30.66,"week52Low":13.5,"pbRate":"8.42","psRate":"2079.79","week52High":44.6,"institutionHeld":0,"latestPrice":31.91,"committee":0.980198,"eps":-9.052203,"divideRate":0,"volume":634641,"delay":0,"ttmEps":-9.052203,"open":31,"prevYearClose":36.31,"prevWeekClose":31.12,"prevMonthClose":32.32,"prevQuarterClose":25.38,"fiveDayClose":32.88,"twentyDayClose":29.51,"sixtyDayClose":18.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ZBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.89,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-1.77},{"market":"US","date":"2026-05-13","symbol":"ZBIO","fiscalQuarterEnding":"2026/03","expectedEps":-1.37,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-1.46},{"market":"US","date":"2026-03-16","symbol":"ZBIO","fiscalQuarterEnding":"2025/12","expectedEps":-1.22,"name":null,"time":"盤前","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-4.54},{"market":"US","date":"2025-11-12","symbol":"ZBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.87,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-1.22},{"market":"US","date":"2025-08-12","symbol":"ZBIO","fiscalQuarterEnding":"2025/06","expectedEps":-1.02,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.25,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1767931200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZBIO","date":"2026-09-14","current":-3.525109,"percent":0.44489,"low":-19.592941,"twenty":-7.317817,"median":-3.950232,"eighty":-2.630511,"high":-1.802568,"avg":-5.282433,"sd":3.679015,"marketCap":2028299619},"quantilePoints":[{"date":"2024-09-13","current":-8.364044,"twenty":-11.189626,"median":-10.130033,"eighty":-9.07044,"marketCap":457989962},{"date":"2024-09-20","current":-12.731934,"twenty":-12.968841,"median":-12.731934,"eighty":-9.523082,"marketCap":697162515},{"date":"2024-09-27","current":-12.564791,"twenty":-13.484804,"median":-12.909978,"eighty":-12.029776,"marketCap":688010267},{"date":"2024-10-04","current":-14.275075,"twenty":-13.747873,"median":-12.811872,"eighty":-12.31335,"marketCap":781660299},{"date":"2024-10-11","current":-13.008553,"twenty":-13.941177,"median":-13.027627,"eighty":-12.397648,"marketCap":712309358},{"date":"2024-10-18","current":-16.373229,"twenty":-14.273549,"median":-13.29848,"eighty":-12.477586,"marketCap":896548905},{"date":"2024-10-25","current":-17.845752,"twenty":-15.022781,"median":-13.503182,"eighty":-12.59822,"marketCap":977179818},{"date":"2024-10-31","current":-16.022265,"twenty":-16.022265,"median":-13.891034,"eighty":-12.731934,"marketCap":877331175},{"date":"2024-11-08","current":-15.961228,"twenty":-15.961228,"median":-14.267446,"eighty":-12.811872,"marketCap":873988961},{"date":"2024-11-15","current":-6.06727,"twenty":-16.022265,"median":-14.202594,"eighty":-12.564791,"marketCap":782495852},{"date":"2024-11-22","current":-3.382919,"twenty":-15.961228,"median":-13.807463,"eighty":-11.896022,"marketCap":436298426},{"date":"2024-11-29","current":-3.729636,"twenty":-15.955124,"median":-13.496851,"eighty":-6.578437,"marketCap":481014835},{"date":"2024-12-06","current":-3.402361,"twenty":-15.898664,"median":-13.178717,"eighty":-4.851473,"marketCap":438805888},{"date":"2024-12-13","current":-2.997318,"twenty":-15.744546,"median":-13.008553,"eighty":-3.729636,"marketCap":386567092},{"date":"2024-12-20","current":-3.162575,"twenty":-15.636205,"median":-12.771903,"eighty":-3.606503,"marketCap":407880521},{"date":"2024-12-27","current":-3.256545,"twenty":-15.585849,"median":-12.510288,"eighty":-3.394584,"marketCap":419999921},{"date":"2025-01-03","current":-2.91955,"twenty":-15.427152,"median":-12.339512,"eighty":-3.24488,"marketCap":376537243},{"date":"2025-01-10","current":-3.007039,"twenty":-15.189107,"median":-10.412935,"eighty":-3.188498,"marketCap":387820823},{"date":"2025-01-17","current":-2.520987,"twenty":-15.022781,"median":-6.676265,"eighty":-3.159983,"marketCap":325134267},{"date":"2025-01-24","current":-2.715408,"twenty":-14.870188,"median":-6.06727,"eighty":-3.071846,"marketCap":350208890},{"date":"2025-01-31","current":-2.469142,"twenty":-14.351372,"median":-4.794107,"eighty":-2.968155,"marketCap":318447701},{"date":"2025-02-07","current":-2.54367,"twenty":-14.313224,"median":-3.888412,"eighty":-2.841781,"marketCap":328059640},{"date":"2025-02-14","current":-2.313605,"twenty":-14.275075,"median":-3.716674,"eighty":-2.653842,"marketCap":298388004},{"date":"2025-02-21","current":-2.530708,"twenty":-14.268972,"median":-3.643766,"eighty":-2.622086,"marketCap":326387998},{"date":"2025-02-28","current":-2.141867,"twenty":-14.163683,"median":-3.476889,"eighty":-2.54367,"marketCap":276238754},{"date":"2025-03-07","current":-2.35573,"twenty":-14.007233,"median":-3.332693,"eighty":-2.517747,"marketCap":303820838},{"date":"2025-03-14","current":-2.324434,"twenty":-13.840892,"median":-3.246824,"eighty":-2.465902,"marketCap":364908203},{"date":"2025-03-21","current":-2.26852,"twenty":-13.569102,"median":-3.188498,"eighty":-2.360915,"marketCap":356130342},{"date":"2025-03-28","current":-2.138053,"twenty":-13.499383,"median":-3.165816,"eighty":-2.351842,"marketCap":335648668},{"date":"2025-04-04","current":-2.076814,"twenty":-13.408148,"median":-3.159335,"eighty":-2.284767,"marketCap":326034820},{"date":"2025-04-11","current":-1.80523,"twenty":-13.315978,"median":-3.071846,"eighty":-2.26652,"marketCap":283399498},{"date":"2025-04-17","current":-2.21793,"twenty":-13.154764,"median":-2.997318,"eighty":-2.257224,"marketCap":348188468},{"date":"2025-04-25","current":-2.657256,"twenty":-13.051602,"median":-2.943853,"eighty":-2.261324,"marketCap":417157373},{"date":"2025-05-02","current":-3.077944,"twenty":-13.023813,"median":-2.968155,"eighty":-2.26639,"marketCap":483200324},{"date":"2025-05-09","current":-2.4756,"twenty":-13.008271,"median":-2.943853,"eighty":-2.269325,"marketCap":388639550},{"date":"2025-05-16","current":-2.503456,"twenty":-12.890356,"median":-2.890387,"eighty":-2.270833,"marketCap":407464932},{"date":"2025-05-23","current":-2.942974,"twenty":-12.763909,"median":-2.866084,"eighty":-2.272453,"marketCap":479001383},{"date":"2025-05-30","current":-2.570283,"twenty":-12.665077,"median":-2.835832,"eighty":-2.278934,"marketCap":418341820},{"date":"2025-06-06","current":-2.470042,"twenty":-12.521189,"median":-2.721889,"eighty":-2.297829,"marketCap":402026489},{"date":"2025-06-13","current":-2.90956,"twenty":-12.426717,"median":-2.835832,"eighty":-2.31327,"marketCap":473562940},{"date":"2025-06-20","current":-2.392933,"twenty":-12.365673,"median":-2.76689,"eighty":-2.315238,"marketCap":389476234},{"date":"2025-06-27","current":-2.608837,"twenty":-12.215932,"median":-2.714219,"eighty":-2.322158,"marketCap":424616947},{"date":"2025-07-03","current":-2.577994,"twenty":-11.896022,"median":-2.691086,"eighty":-2.323707,"marketCap":419596845},{"date":"2025-07-11","current":-3.102331,"twenty":-8.929847,"median":-2.679496,"eighty":-2.324434,"marketCap":504938576},{"date":"2025-07-18","current":-3.387633,"twenty":-8.364044,"median":-2.699206,"eighty":-2.336288,"marketCap":551374518},{"date":"2025-07-25","current":-4.194702,"twenty":-6.676265,"median":-2.718649,"eighty":-2.349239,"marketCap":682733850},{"date":"2025-08-01","current":-4.037914,"twenty":-6.187126,"median":-2.829882,"eighty":-2.35573,"marketCap":657214999},{"date":"2025-08-08","current":-3.804019,"twenty":-6.06727,"median":-2.865865,"eighty":-2.35573,"marketCap":619145893},{"date":"2025-08-15","current":-3.987237,"twenty":-5.542498,"median":-2.90956,"eighty":-2.36209,"marketCap":705768845},{"date":"2025-08-22","current":-4.02768,"twenty":-4.889717,"median":-2.928692,"eighty":-2.362211,"marketCap":712927599},{"date":"2025-08-29","current":-3.868286,"twenty":-4.698498,"median":-2.950685,"eighty":-2.372371,"marketCap":684713689},{"date":"2025-09-05","current":-4.039575,"twenty":-4.396216,"median":-2.982091,"eighty":-2.374493,"marketCap":715033114},{"date":"2025-09-12","current":-4.798483,"twenty":-4.881439,"median":-2.99503,"eighty":-2.389351,"marketCap":849365013},{"date":"2025-09-19","current":-4.629572,"twenty":-4.881439,"median":-3.063777,"eighty":-2.399463,"marketCap":819466690},{"date":"2025-09-26","current":-4.429735,"twenty":-4.835595,"median":-3.074895,"eighty":-2.402603,"marketCap":784094028},{"date":"2025-10-03","current":-4.984046,"twenty":-4.911724,"median":-3.083269,"eighty":-2.409912,"marketCap":882211057},{"date":"2025-10-10","current":-6.604159,"twenty":-5.180553,"median":-3.135974,"eighty":-2.413574,"marketCap":1168982288},{"date":"2025-10-17","current":-5.759607,"twenty":-5.320916,"median":-3.162575,"eighty":-2.420654,"marketCap":1019490677},{"date":"2025-10-24","current":-5.949928,"twenty":-5.76722,"median":-3.174048,"eighty":-2.42495,"marketCap":1053178928},{"date":"2025-10-31","current":-9.035303,"twenty":-6.083769,"median":-3.188498,"eighty":-2.432369,"marketCap":1599311910},{"date":"2025-11-07","current":-9.81546,"twenty":-6.198298,"median":-3.245204,"eighty":-2.444339,"marketCap":1737405107},{"date":"2025-11-14","current":-10.08009,"twenty":-6.457611,"median":-3.282468,"eighty":-2.446909,"marketCap":1914199059},{"date":"2025-11-21","current":-9.848299,"twenty":-7.258864,"median":-3.371139,"eighty":-2.451734,"marketCap":1870182143},{"date":"2025-11-28","current":-10.976161,"twenty":-8.972029,"median":-3.394997,"eighty":-2.453948,"marketCap":2084362015},{"date":"2025-12-05","current":-10.772637,"twenty":-9.459248,"median":-3.515773,"eighty":-2.459247,"marketCap":2045713016},{"date":"2025-12-12","current":-11.366249,"twenty":-9.83041,"median":-3.643766,"eighty":-2.466418,"marketCap":2158439264},{"date":"2025-12-19","current":-9.913314,"twenty":-9.980024,"median":-3.678075,"eighty":-2.469682,"marketCap":1882528351},{"date":"2025-12-26","current":-12.202958,"twenty":-10.134363,"median":-3.729636,"eighty":-2.472265,"marketCap":2317329596},{"date":"2026-01-02","current":-10.263827,"twenty":-10.232168,"median":-3.760324,"eighty":-2.476253,"marketCap":1949090517},{"date":"2026-01-09","current":-4.638651,"twenty":-10.207521,"median":-3.79333,"eighty":-2.479511,"marketCap":880875114},{"date":"2026-01-16","current":-5.633657,"twenty":-10.159019,"median":-3.831007,"eighty":-2.483289,"marketCap":1069825778},{"date":"2026-01-23","current":-5.766513,"twenty":-10.142278,"median":-3.88256,"eighty":-2.488034,"marketCap":1095054986},{"date":"2026-01-30","current":-5.902195,"twenty":-10.122491,"median":-3.950232,"eighty":-2.490604,"marketCap":1120820986},{"date":"2026-02-06","current":-5.938943,"twenty":-10.119664,"median":-3.975342,"eighty":-2.498305,"marketCap":1127799277},{"date":"2026-02-13","current":-7.380571,"twenty":-10.08009,"median":-4.008147,"eighty":-2.503456,"marketCap":1401563024},{"date":"2026-02-20","current":-7.637803,"twenty":-9.946669,"median":-4.026371,"eighty":-2.50452,"marketCap":1450411065},{"date":"2026-02-27","current":-7.451239,"twenty":-9.897484,"median":-4.035344,"eighty":-2.514003,"marketCap":1414982815},{"date":"2026-03-06","current":-7.140299,"twenty":-9.857345,"median":-4.041954,"eighty":-2.520051,"marketCap":1355935733},{"date":"2026-03-13","current":-6.925469,"twenty":-9.824447,"median":-4.068124,"eighty":-2.528764,"marketCap":1315139567},{"date":"2026-03-20","current":-3.549457,"twenty":-9.816065,"median":-4.041954,"eighty":-2.535893,"marketCap":1340761298},{"date":"2026-03-27","current":-3.365681,"twenty":-9.764845,"median":-4.035344,"eighty":-2.542374,"marketCap":1271342335},{"date":"2026-04-02","current":-3.206266,"twenty":-9.752191,"median":-4.02768,"eighty":-2.54367,"marketCap":1211125146},{"date":"2026-04-10","current":-3.351146,"twenty":-9.585134,"median":-4.008147,"eighty":-2.555011,"marketCap":1265851823},{"date":"2026-04-17","current":-3.426736,"twenty":-9.459248,"median":-3.975342,"eighty":-2.562572,"marketCap":1294404871},{"date":"2026-04-24","current":-2.91178,"twenty":-9.318941,"median":-3.950232,"eighty":-2.56484,"marketCap":1099887227},{"date":"2026-05-01","current":-3.042488,"twenty":-9.220114,"median":-3.88256,"eighty":-2.568711,"marketCap":1149260207},{"date":"2026-05-08","current":-3.034614,"twenty":-9.118797,"median":-3.818719,"eighty":-2.573367,"marketCap":1146285931},{"date":"2026-05-15","current":-2.806581,"twenty":-9.04377,"median":-3.782641,"eighty":-2.576966,"marketCap":1193220825},{"date":"2026-05-22","current":-2.946168,"twenty":-8.972029,"median":-3.74498,"eighty":-2.576966,"marketCap":1252566199},{"date":"2026-05-29","current":-2.756092,"twenty":-8.703526,"median":-3.716674,"eighty":-2.577994,"marketCap":1171755477},{"date":"2026-06-05","current":-2.729363,"twenty":-8.073548,"median":-3.672934,"eighty":-2.577994,"marketCap":1160391469},{"date":"2026-06-12","current":-2.637295,"twenty":-7.609535,"median":-3.597675,"eighty":-2.580331,"marketCap":1121248775},{"date":"2026-06-18","current":-2.759062,"twenty":-7.566764,"median":-3.544789,"eighty":-2.584211,"marketCap":1173018144},{"date":"2026-06-26","current":-3.663405,"twenty":-7.560564,"median":-3.528998,"eighty":-2.58741,"marketCap":1557500410},{"date":"2026-07-02","current":-4.157898,"twenty":-7.541694,"median":-3.549457,"eighty":-2.594231,"marketCap":1767734556},{"date":"2026-07-10","current":-4.370248,"twenty":-7.462546,"median":-3.643766,"eighty":-2.595516,"marketCap":1858015285},{"date":"2026-07-17","current":-4.193537,"twenty":-7.451239,"median":-3.672934,"eighty":-2.596017,"marketCap":1782886566},{"date":"2026-07-24","current":-4.601902,"twenty":-7.448412,"median":-3.716674,"eighty":-2.598756,"marketCap":1956503353},{"date":"2026-07-31","current":-4.791978,"twenty":-7.400923,"median":-3.74498,"eighty":-2.598756,"marketCap":2037314075},{"date":"2026-08-07","current":-4.777128,"twenty":-7.389051,"median":-3.770746,"eighty":-2.606821,"marketCap":2031000738},{"date":"2026-08-14","current":-3.929032,"twenty":-7.382267,"median":-3.79905,"eighty":-2.610296,"marketCap":1903160311},{"date":"2026-08-21","current":-4.254657,"twenty":-7.371525,"median":-3.831007,"eighty":-2.614149,"marketCap":2060887981},{"date":"2026-08-28","current":-4.389213,"twenty":-7.360218,"median":-3.875423,"eighty":-2.618299,"marketCap":2126064704},{"date":"2026-09-04","current":-4.42958,"twenty":-7.333082,"median":-3.927729,"eighty":-2.626159,"marketCap":2145617721},{"date":"2026-09-11","current":-4.184688,"twenty":-7.320079,"median":-3.939657,"eighty":-2.629863,"marketCap":2026996085},{"date":"2026-09-14","current":-4.187379,"twenty":-7.317817,"median":-3.950232,"eighty":-2.630511,"marketCap":2028299619}],"updateTime":1789475741221},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZBIO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158836638","title":"Zenas BioPharma提交招股文件：賣股股東擬發售最高700萬股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1158836638","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158836638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:51","pubTimestamp":1789159869,"startTime":"0","endTime":"0","summary":"Zenas BioPharma Inc.已向美国证券交易委员会（SEC）提交文件，计划由卖股股东发售最多700万股普通股。这一消息源自该公司最新公布的监管申报文件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194910745","title":"Zenas Biopharma宣佈Obexelimab三期INDIGO試驗達成主要及所有關鍵次要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1194910745","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194910745?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 07:19","pubTimestamp":1780442370,"startTime":"0","endTime":"0","summary":"Zenas Biopharma Inc. 公布，其候选药物Obexelimab在针对免疫球蛋白G4相关疾病（IgG4-RD）的关键注册性三期INDIGO试验中，成功达成了主要终点以及所有关键的次要终点。\n相关数据已在2026年欧洲抗风湿病联盟（EULAR）大会上同步发布，并同期发表于《新英格兰医学杂志》。试验结果显示，Obexelimab治疗显著降低了糖皮质激素的使用剂量及其相关毒性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107172672","title":"Zenas BioPharma公布Obexelimab治療IgG4相關疾病關鍵3期INDIGO試驗數據，同步亮相EULAR 2026大會並發表於《新英格蘭醫學雜誌》","url":"https://stock-news.laohu8.com/highlight/detail?id=1107172672","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107172672?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 07:05","pubTimestamp":1780441543,"startTime":"0","endTime":"0","summary":"Zenas BioPharma公司公布了其候选药物Obexelimab用于治疗免疫球蛋白G4相关疾病（IgG4-RD）的关键性3期INDIGO试验的完整数据。这一重要临床研究成果实现了双重发布：既在欧洲抗风湿病联盟2026年大会上进行了同步展示，也同时刊登在权威的《新英格兰医学杂志》上。\n该注册性3期试验达到了其主要终点和所有关键的次要终点，数据显示Obexelimab治疗为IgG4-RD患者带来了具有统计学意义和临床意义的显著改善。这一积极结果标志着该药物在应对这一慢性、免疫介导的纤维炎症性疾病方面迈出了关键一步，为该药的后续监管提交奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110830833","title":"Zenas BioPharma宣佈向美國FDA提交Obexelimab治療IgG4-RD的生物製品許可申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1110830833","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110830833?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 19:09","pubTimestamp":1779966556,"startTime":"0","endTime":"0","summary":"Zenas BioPharma Inc. 已正式向美国食品药品监督管理局提交了其候选药物Obexelimab用于治疗免疫球蛋白G4相关疾病的生物制品许可申请。此举标志着该药物在监管审批进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120448524","title":"異動解讀 | 澤納斯生物製藥盤前大漲6.45%，因將公布關鍵藥物3期試驗結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1120448524","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120448524?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 19:23","pubTimestamp":1779189818,"startTime":"0","endTime":"0","summary":"泽纳斯生物制药（ZBIO）今日盘前股价大涨6.45%，引起了市场的广泛关注。消息面上，公司宣布其针对奥贝昔利单抗在免疫球蛋白G4相关疾病治疗中的3期INDIGO注册试验结果，即将在2026年欧洲抗风湿病联盟大会上正式公布。这一关键数据的披露标志着该药物在应对这一复杂自身免疫性疾病方面取得了重要进展，INDIGO试验作为注册性研究，其成果对于评估药物的疗效与安全性至关重要，有望为患者带来新的治疗选择，因此吸引了全球风湿免疫学领域专家与投资者的密切关注。此次试验结果的公布被视为公司研发管线中的重要里程碑，市场预期积极的数据可能为药物未来的商业化铺平道路，从而推动了股价在盘前交易时段显著上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107292388","title":"澤納斯生物製藥宣佈將在2026年歐洲抗風濕病聯盟大會上公布奧貝昔利單抗治療IgG4相關疾病的3期INDIGO註冊試驗結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1107292388","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107292388?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 19:06","pubTimestamp":1779188794,"startTime":"0","endTime":"0","summary":"泽纳斯生物制药公司近日宣布，其针对奥贝昔利单抗在免疫球蛋白G4相关疾病治疗中的3期INDIGO注册试验结果，即将在2026年欧洲抗风湿病联盟大会上正式公布。这一关键数据的披露，标志着该药物在应对这一复杂自身免疫性疾病方面取得了重要进展。INDIGO试验作为一项注册性研究，其成果对于评估奥贝昔利单抗的疗效与安全性至关重要，有望为IgG4-RD患者带来新的治疗选择。公司计划在大会上详细展示试验数据，届时将吸引全球风湿免疫学领域的专家与投资者的密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103707231","title":"Zenas Biopharma宣佈其潛在同類最佳口服IL-17Aa/Af抑制劑ZB021完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1103707231","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103707231?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 18:52","pubTimestamp":1778669521,"startTime":"0","endTime":"0","summary":"Zenas BioPharma公司宣布，其新型、潜在同类最佳的口服IL-17Aa/Af抑制剂ZB021的1期临床试验已完成首例受试者给药。\n该里程碑标志着这款旨在治疗多种自身免疫性疾病的候选药物正式进入临床开发阶段。IL-17A是驱动多种炎症性疾病病理过程的关键细胞因子，ZB021作为一种口服抑制剂，旨在精准靶向其特定亚型Aa和Af，有望为患者提供一种新的治疗选择。\n公司对推进该项目的临床开发充满期待，以评估其安全性、耐受性及药代动力学特性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622876581","title":"BUZZ--美國股票走勢-Entergy 公司、IDEX 公司、廣達服務公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2622876581","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622876581?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 23:49","pubTimestamp":1774626562,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI下跌0.71%，报45,632.17点。标普500指数.SPX下跌0.67%，报6,433.77点；纳斯达克综合指数.IXIC下跌1.07%，报21,179.27点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL4S40F19K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FPS","SST","CRWD","ICOI","ZBIO","BTGO","SHPH","ITRM","GGLS","ADMA","PHAT","DIS","HKIT","RCKT","FTNT","FIAT","02026","LTRN","VOR","CONX","ITRMF","IEX","PH","HON","SAIL","ETR","ETN","FCHL","DISO","GGLL","DDOG","CCL","AGX","AME","EMR","ARTL","DOV","TWO","CCL.UK","CONI","BKSY","PANW","PWR","VATE","ANAB","WIX","DTCX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622765898","title":"BUZZ--美國股票走勢-Entergy 公司、IDEX 公司、廣達服務公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2622765898","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622765898?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 23:49","pubTimestamp":1774626562,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI下跌0.71%，报45,632.17点。标普500指数.SPX下跌0.67%，报6,433.77点；纳斯达克综合指数.IXIC下跌1.07%，报21,179.27点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL4T40F19K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITRMF","GOOW","IEX","PALD","RCKT","DIS","ITRM","PHAT","COIW","CRWD","CCL.UK","HON","CCL","SHPH","SST","PANW","TWO","HKIT","02026","PANG","VATE","BTGO","LTRN","VOR","DTCX","ADMA","ANAB","BKSY","EMR","FTNT","SAIL","DDOG","ZBIO","FCHL","ETN","PH","ARTL","COIG","DOV","CONY","FPS","AME","PWR","AGX","ETR","WIX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1123848176","title":"Zenas BioPharma完成3億美元融資：發行可轉債與普通股，加速自免藥物開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1123848176","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123848176?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 12:13","pubTimestamp":1774584809,"startTime":"0","endTime":"0","summary":"Zenas BioPharma完成3亿美元融资：发行可转债与普通股，加速自免药物开发生物制药公司Zenas BioPharma宣布，已完成同时公开发行2032年到期的2.50%可转换优先票据和普通股，募集资金总额达3亿美元。公司计划将净收益主要用于推进obexelimab的全球三期临床试验，以及其他早期自免候选药物的研究。自免疾病赛道竞争加剧Zenas BioPharma专注于开发针对自身免疫性疾病的创新疗法。此次融资将为Zenas提供充足的资金跑道，支持其关键临床试验的推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622089145","title":"BUZZ-Zenas 生物製藥公司因發行可轉換債券和股票而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2622089145","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622089145?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 05:16","pubTimestamp":1774559764,"startTime":"0","endTime":"0","summary":"3月26日 - ** Zenas BioPharma <ZBIO.O>股价在筹资消息公布后盘后下跌9.8%，至20美元。** ZBIO公司股票周四收盘下跌0.1%，报22.16美元。在 2025 年股价飙升四倍多之后，今年以来股价下跌 39%。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nL4T40E1SJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU2456880835.USD","LU2360032135.SGD","LU1244550494.USD","LU0170899867.USD","LU1267930227.SGD","BK4139","BK4534","ZBIO","BK4566","LU2125154778.USD","BK4207","LU1366192091.USD","LU0648001328.SGD","LU0320765646.SGD","LU0477156953.USD","LU1506573853.SGD","LU1162221912.USD","LU0130517989.USD","LU0098860793.USD","LU1668664300.SGD","LU0072461881.USD","LU2462157665.USD","BK4559","BK4585","LU1791807156.HKD","EVR","LU1244550221.USD","BK4504","LU0314106906.USD","LU0128525689.USD","LU0130102774.USD","LU2236285917.USD","BK4127","LU2125154935.USD","LU0980610538.SGD","BK4588","LU1244550577.SGD","LU0052756011.USD","LU0310800965.SGD","LU1201861249.SGD","LU0106831901.USD","IE00BSNM7G36.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133548955","title":"Zenas BioPharma Inc. 融資收益將用於支持Obexelimab美國上市、管線推進及一般企業用途","url":"https://stock-news.laohu8.com/highlight/detail?id=1133548955","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133548955?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 04:03","pubTimestamp":1774555391,"startTime":"0","endTime":"0","summary":"Zenas BioPharma Inc. 近日宣布，其通过融资所获收益将专项用于支持其核心产品Obexelimab在美国市场的商业化上市准备工作。此外，部分资金也将用于推动公司研发管线的进一步拓展，以及其他一般企业运营目的。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148820224","title":"Zenas BioPharma宣佈擬同步公開發行2032年到期可轉換優先票據及普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1148820224","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148820224?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 04:02","pubTimestamp":1774555361,"startTime":"0","endTime":"0","summary":"Zenas BioPharma Inc.披露了同步进行两项公开募资的计划：发行2032年到期的可转换优先票据，以及公司普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126645156","title":"Zenas BioPharma 公布2025年第四季度及全年財務業績並更新公司進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1126645156","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126645156?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 19:01","pubTimestamp":1773658872,"startTime":"0","endTime":"0","summary":"Zenas BioPharma Inc. (ZBIO) 已正式发布其2025年第四季度及全年的财务报告。此次公告同时包含了公司最新的运营动态与发展规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}